Literature DB >> 34193403

Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al.

Veerle Stouten1, René Westhovens1,2, Sofia Pazmino1, Diederik De Cock1, Kristien Van der Elst2, Johan Joly2, Delphine Bertrand1, Patrick Verschueren3,2.   

Abstract

Entities:  

Keywords:  arthritis; glucocorticoids; methotrexate; rheumatoid

Year:  2021        PMID： 34193403     DOI： 10.1136/annrheumdis-2021-220857

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  1 in total

1.  Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.

Authors:  Bernard G Combe; Yoshiya Tanaka; Maya H Buch; Peter Nash; Gerd R Burmester; Alan J Kivitz; Beatrix Bartok; Alena Pechonkina; Katrina Xia; Kahaku Emoto; Shungo Kano; Thijs K Hendrikx; Robert B M Landewé; Daniel Aletaha
Journal:  Rheumatol Ther       Date:  2022-10-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.